Back to search

Sweden· SE-19900928000053

Antithrombin III Baxalta Pulver och vätska till injektions-/infusionsvätska, lösning

A medicinal product containing antithrombin iii, registered in Sweden by Baxalta Innovations GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAntithrombin III Baxalta Pulver och v…ATC—REGISTER NO.SE-19900928000053PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Antithrombin Iii
Manufacturer
Baxalta Innovations GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19900928000053

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Antithrombin iii in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All antithrombin iii products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Antithrombin Iii Takeda, Atenativ
  • Belgium · Antithrombin Iii Konzentrat Baxalta, Antitrombine Iii-Concentraat Baxalta
  • Bulgaria · Антитромбин Iii Nf Получен От Човешка Плазма Баксалта, Атенатив
  • Czechia · Anbinex, Antithrombin Iii Baxalta
  • Germany · Anbinex, Atenativ
  • Denmark · Antitrombin Iii Baxalta, Atenativ
  • Estonia · Atenativ
  • Spain · Anbinex, Kybernin P
  • Finland · Atenativ
  • France · Aclotine, Atenativ
  • Greece · Kybernin P
  • Croatia · Antithrombin Iii Baxalta, Atenativ
  • Hungary · Antithrombin Iii Baxalta, Atenativ
  • Italy · Anbinex, Anternaty
  • Lithuania · Atenativ
  • Luxembourg · Kybernin P
  • Latvia · Atenativ
  • Malta · Antithrombin Iii Baxalta
  • Netherlands · Antitrombine Iii Concentraat Baxalta, Atenativ
  • Norway · Atenativ
  • Poland · Anbinex, Antithrombin Iii Nf Takeda
  • Portugal · Anbinex, Atenativ
  • Romania · Atenativ
  • Slovenia · Atenativ, Kybernin P
  • Slovakia · Anbinex, Antithrombin Iii Ľudský Antitrombín Iii Získaný Z Plazmy Baxalta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5aef0feb-8c05-4771-abff-d8bd0e5c554d
GET /v1/drugs/5aef0feb-8c05-4771-abff-d8bd0e5c554d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "19900928000053",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19900928000053",
  "product_doc_link": "https://docetp.mpa.se/LMF/Antithrombin%20III%20Baxalta%20powder%20and%20solvent%20for%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee807a303e.pdf"
}

See everything about antithrombin iii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.